Tenderwize
Wróć do wyszukiwania

Open House Discount Contracts for Omalizumab

AOK Rheinland-Pfalz/Saarland - Die Gesundheitskasse·Eisenberg, Germany·Deadline Feb 28, 2027 · 187 days left·Open·Supplies
Structured notice only
Oryginalny tytuł ogłoszenia

Germany – Pharmaceutical products – Open house Arzneimittelrabattverträge zum Wirkstoff Omalizumab, ATC R03DX05

30/100

Ocena szansy

Needs reviewLow complexity
SuppliesOpen
Skąd ta ocena?

Szansa

30 / 100

Złożoność

20 / 100

Czynniki ryzyka

No indication of expected sales volume or number of patients; the discount may not generate significant revenue.

The buyer may replace open house contracts with exclusive ones from a separate tender, automatically ending all open ho...

Głęboka analiza portfolio

Głęboka analiza dopasowania firmy

Wykorzystuje:

  • Description
  • Industries & Services
  • Capabilities
  • Market & Experience
  • Certifications

Przegląd

Moderate opportunity

Kluczowe fakty

  • Supplies contract
  • 1 lot
  • Duration until Apr 2027
  • Conclusion of non-exclusive discount contracts (Rabattverträge) under German Social Code (§§ 130a Abs. 8/130c Abs. 1 SGB V) for Omalizumab.
  • Contracts are open to all pharmaceutical companies that supply authorized and marketable Omalizumab products in Germany.
Pokaż pełne podsumowanie

Open house (non-exclusive) discount contracts for pharmaceutical products containing the active substance Omalizumab (ATC R03DX05), offered by AOK Rheinland-Pfalz/Saarland. The model allows any interested pharmaceutical company to enter into a standard agreement at any time during the 24-month period (May 2025 – April 2027). No competitive selection; all qualified applicants are accepted. The first contracts start 1 May 2025; initial application deadline is 31 March 2025. Later enrollments are possible monthly. The buyer may replace these non-exclusive contracts with exclusive ones during the term. The notice is published voluntarily for transparency; it is not a public procurement under EU directives.

Ryzyka

No indication of expected sales volume or number of patients; the discount may not generate significant revenue.

The buyer may replace open house contracts with exclusive ones from a separate tender, automatically ending all open ho...

Analiza może być niepełna

Przeanalizowano tylko część dokumentacji. Pozostałe dokumenty mogą zawierać dodatkowe wymagania, certyfikaty lub dokumenty do złożenia.

Kluczowe wymagania

Technical

  • Provide authorized and marketable Omalizumab products in Germany (proof via Lauer-Taxe listing or AMIce database extracts).

Administrative

  • Submit signed contract documents and required annexes by applicable deadline.
  • No electronic submission; paper documents required (original by mail or courier).

Wymagania mogą być niepełne.

Kryteria udzielenia

Lot 1

No award criteria defined; all eligible participants are accepted.

Zamawiający

Lokalizacja

Eisenberg, DEU

Profil zamawiającego

Otwórz profil

Identyfikator

DE271900642

Działalność

Health

Części (1)

LOT-0001

Open House Discount Contracts for Omalizumab

Non-exclusive framework discount contracts for Omalizumab (ATC R03DX05). All pharmaceutical companies with authorized and marketable products in Germany can join. Standard terms, no negotiation. Max duration 24 months from earliest start (May 2025). Contracts end automatically if replaced by exclusive contracts from a separate tender.

SuppliesEU fundedElectronic submission

Lokalizacja

Eisenberg, Germany

Czas trwania

Apr 2025 - Apr 2027

Kategoria

Pharmaceutical products

Kryteria udzielenia

No award criteria defined; all eligible participants are accepted.

Termin

Deadline Feb 28, 2027

Szczegóły zamówienia

Data publikacji
12 Mar 2025
Języki
German

Metadane referencyjne

Podstawa prawna
32014L0024

Identyfikatory referencyjne

ID przetargu
163311-2025

Dokumenty (1)

Podobne przetargi